Literature DB >> 16916000

MR imaging in the management of patients with breast cancer.

Gillian Maclaine Newstead1.   

Abstract

Magnetic resonance (MR) imaging has high sensitivity in detecting and determining the extent of breast cancer and the information provided by this modality has proven valuable in patient management. Investigations defining the strengths of MR imaging, technical advances, and greater standardization of protocols have led to its increased use in patients with breast cancer, both before and following treatment. This article reviews techniques and procedures used in the performance and interpretation of breast MR examinations. Applications of MR imaging in the management of patients with breast cancer are also summarized, including preoperative evaluation of extent of disease, postoperative assessment of residual disease, and the detection of recurrent carcinoma. The use of MR imaging to evaluate patient response to chemotherapy and to assess patients with axillary lymph node metastases with an unknown primary lesion will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916000     DOI: 10.1053/j.sult.2006.05.006

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  3 in total

1.  Breast Cancer in Special Situations.

Authors:  Bernd Gerber
Journal:  Breast Care (Basel)       Date:  2008-06-19       Impact factor: 2.860

2.  The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast.

Authors:  Sanaz A Jansen; Akiko Shimauchi; Lindsay Zak; Xiaobing Fan; Gregory S Karczmar; Gillian M Newstead
Journal:  J Magn Reson Imaging       Date:  2011-06       Impact factor: 4.813

3.  Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition.

Authors:  Sanaz A Jansen; Akiko Shimauchi; Lindsay Zak; Xiaobing Fan; Abbie M Wood; Gregory S Karczmar; Gillian M Newstead
Journal:  AJR Am J Roentgenol       Date:  2009-09       Impact factor: 3.959

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.